Drug shortages are not a rare event for hospital pharmacies anymore. They are a recurring operational reality, and the hospitals that handle them best are rarely the ones scrambling to find a substitute product the day a shortage notice goes out. The pharmacies that manage shortages with the least disruption to patient care tend to share one trait: they built their response plan during a quiet period, not in the middle of an active shortage.
Most hospital pharmacies that weather shortages with the least disruption have already identified backup pharmacy distributors in newyork and elsewhere before a shortage hits, rather than starting that search once a critical product is already unavailable. Preparation, not reaction, is what separates a manageable supply gap from a clinical crisis.
Why Drug Shortages Keep Recurring
Shortages tend to cluster around sterile injectables, generic oncology drugs, and other products with thin manufacturing margins, where a single plant disruption can affect the entire national supply. Many of these products have only a small number of active manufacturers to begin with, so there is little redundancy left in the system once one facility runs into a quality or capacity problem. The FDA's drug shortage database tracks these disruptions in real time, and hospital pharmacies that check it regularly, rather than only after a shortage affects them directly, get more lead time to respond.
"89 new drug shortages were recorded in 2025, the lowest annual total since 2006, though 216 shortages remained active as the year closed, and roughly 15% of active shortages involve controlled substances." — American Society of Health-System Pharmacists, Year-End Drug Shortage Report, January 2026
The lowest new-shortage count in nearly two decades sounds like good news, and in one sense it is. But three-quarters of the shortages still active today started in 2022 or earlier, which means hospital pharmacies are managing long-running gaps on top of whatever new disruptions occur, not instead of them. A pharmacy department that only tracks new shortage announcements, without also monitoring the status of its existing gaps, can miss a resolution or a further deterioration in an already-strained product line.
Build Redundancy With A Pharma Wholesaler In Newyork
One of the more practical ways to reduce exposure is to diversify sourcing for the therapeutic categories most prone to shortage before those categories become a problem. Confirming that a pharmaceutical distributor in newyork carries adequate stock of frequently short-supply sterile injectables and generic oncology products, and can activate that supply quickly, gives a pharmacy department a second option that a single-wholesaler relationship does not provide.
Building A Shortage Response Plan With Pharmacy Distributors In Newyork
A written shortage response plan, built before a shortage occurs, typically covers:
- Early warning monitoring: Assign staff to check the FDA and ASHP shortage lists on a set schedule, not only when a nurse or physician flags an unavailable product.
- Backup sourcing: Maintain a working relationship with at least one wholesale pharmaceutical distributors in newyork option beyond the pharmacy's primary supplier for high-risk therapeutic categories.
- Therapeutic interchange protocols: Pre-approve clinically appropriate substitutes through pharmacy and therapeutics committee review, so a shortage does not require an emergency committee meeting.
- Inventory visibility: Track on-hand quantities and burn rates for high-risk drugs closely enough to flag a developing shortage before the shelf is empty.
- Escalation contacts: Keep current contact information for account managers at every distributor relationship, so a shortage inquiry does not start with a general customer service line.
- Documentation review: Revisit the plan at least twice a year, since staff turnover and formulary changes can quietly make an otherwise solid plan outdated.
None of these steps require significant investment on their own, but skipping any one of them tends to show up as delay during an actual shortage, when delay is exactly what a hospital pharmacy can least afford.
A community hospital pharmacy in New York recently avoided a multi-week gap in a commonly used sterile injectable by having a pre-qualified pharmacy distributors in newyork relationship already in place when its primary wholesaler placed the product on allocation. Because the pharmacy had already vetted the backup distributor's licensing and product availability months earlier, the switch took a phone call rather than a multi-day onboarding process.
Comparing pharmaceutical wholesalers in newyork on their shortage-response capability specifically, not just routine pricing and delivery, is what turns a shortage response plan from a document into something that actually works under pressure. A distributor that cannot answer basic questions about allocation policy or lead times during a normal week is unlikely to perform better during an actual shortage.
No single distributor relationship, however strong, fully insulates a hospital pharmacy from a nationwide shortage. Drugzone Pharmaceuticals Inc. is licensed in all 50 U.S. states, NABP-accredited, FDA-registered, and DSCSA-compliant, with more than 2,000 generic pharmaceutical SKUs and a 20,000 sq. ft. temperature-controlled distribution facility supporting consistent availability. Speak With a Distribution Specialist to discuss adding Drugzone to your hospital pharmacy's shortage response plan before the next disruption hits.
Frequently Asked Questions
Q: Why do drug shortages keep happening even as new shortage counts decline?
Most active shortages today started years ago and have not fully resolved, so a lower count of new shortages does not eliminate the long-running gaps hospital pharmacies are already managing. New disruptions add to that existing backlog rather than replacing it.
Q: What should be in a hospital pharmacy's shortage response plan?
At minimum, a plan should cover early warning monitoring, a pre-vetted backup distributor relationship, pre-approved therapeutic interchange protocols, inventory tracking for high-risk drugs, and current escalation contacts at every supplier relationship.
Q: How do hospital pharmacies find a reliable pharmacy distributors in newyork option for backup sourcing?
Start with licensing verification, NABP accreditation, and FDA registration, then ask specifically about allocation policy and lead times for the therapeutic categories most prone to shortage, since that response capability is what matters most during an actual disruption.
Q: Should therapeutic substitutions be decided during a shortage or in advance?
In advance, whenever possible. Pre-approving clinically appropriate substitutes through pharmacy and therapeutics committee review removes the need for an emergency decision under time pressure once a shortage is already affecting patient care.
Q: Which drug categories are most likely to experience a shortage?
Sterile injectables, generic oncology drugs, and other products with thin manufacturing margins are disproportionately represented in shortage data, since a single plant disruption in those categories can affect a large share of national supply. Controlled substances also make up a meaningful share of current shortages, which adds regulatory complexity to an already difficult sourcing problem.
Sign in to leave a comment.